Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents

Diagnostic Microbiology and Infectious Disease

Volumn 58, Issue 1, 2007, Pages 41-47

  Tsuji, Brian T ^a,c,e   Rybak, Michael J ^a,b,c   Cheung, Chrissy M ^a   Amjad, Muhammad ^a,b   Kaatz, Glenn W ^a,b,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

AGR; CAMRSA; HAMRSA; Mec type; Sec mec type

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LEVOFLOXACIN; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; TEICOPLANIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; COMMUNITY ASSESSMENT; COMMUNITY CARE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE CASSETTE; GENE CLUSTER; GENE FUNCTION; HEALTH CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHROMOSOMES, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; EPIDEMIOLOGY, MOLECULAR; EXOTOXINS; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS;

EID: 34247869026     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2006.10.021     Document Type: Article

References (29)

1. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., and Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 (2002) 1819-1827
2. Baggett H.C., Hennessy T.W., Rudolph K., Bruden D., Reasonover A., Parkinson A., Sparks R., Donlan R.M., Martinez P., Mongkolrattanothai K., and Butler J.C. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J. Infect. Dis. 189 (2004) 1565-1573
3. Carleton H.A., Diep B.A., Charlebois E.D., Sensabaugh G.F., and Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J. Infect. Dis. 190 (2004) 1730-1738
4. Chambers H.F. Community-associated MRSA-resistance and virulence converge. N. Engl. J. Med. 352 (2005) 1485-1487
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement M100-S15 (2005), CLSI, Wayne, PA
6. Dufour P., Gillet Y., Bes M., Lina G., Vandenesch F., Floret D., Etienne J., and Richet H. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis. 35 (2002) 819-824
7. Eguia J.M., and Chambers H.F. Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr. Infect. Dis. Rep. 5 (2003) 459-466
8. Fiebelkorn K.R., Crawford S.A., McElmeel M.L., and Jorgensen J.H. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J. Clin. Microbiol. 41 (2003) 4740-4744
9. Folden D.V., Machayya J.A., Sahmoun A.E., Beal J.R., Holzman G.S., Helgerson S.D., and Lo T.S. Estimating the proportion of community-associated methicillin-resistant Staphylococcus aureus: two definitions used in the USA yield dramatically different estimates. J. Hosp. Infect. 60 (2005) 329-332
10. Fowler Jr. V.G., Sakoulas G., McIntyre L.M., Meka V.G., Arbeit R.D., Cabell C.H., Stryjewski M.E., Eliopoulos G.M., Reller L.B., Corey G.R., Jones T., Lucindo N., Yeaman M.R., and Bayer A.S. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190 (2004) 1140-1149
11. Fridkin S.K., Hageman J.C., Morrison M., Sanza L.T., Como-Sabetti K., Jernigan J.A., Harriman K., Harrison L.H., Lynfield R., and Farley M.M. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352 (2005) 1436-1444
12. Gillet Y., Issartel B., Vanhems P., Fournet J.C., Lina G., Bes M., Vandenesch F., Piemont Y., Brousse N., Floret D., and Etienne J. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359 (2002) 753-759
13. Goering R.V., and Winters M.A. Rapid method for epidemiological evaluation of Gram-positive cocci by field inversion gel electrophoresis. J. Clin. Microbiol. 30 (1992) 577-580
14. Grim S.A., Rapp R.P., Martin C.A., and Evans M.E. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy 25 (2005) 253-264
15. Huang V., Brown W.J., and Rybak M.J. In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci. Antimicrob. Agents. Chemother. 48 (2004) 2719-2723
16. Lesens O., Hansmann Y., Brannigan E., Hopkins S., Meyer P., O'Connel B., Prevost G., Bergin C., and Christmann D. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?. Infect.Control. Hosp. Epidemiol. 26 (2005) 204-209
17. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., and Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
18. Miller L.G., Perdreau-Remington F., Rieg G., Mehdi S., Perlroth J., Bayer A.S., Tang A.W., Phung T.O., and Spellberg B. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N. Engl. J. Med. 352 (2005) 1445-1453
19. Naimi T.S., LeDell K.H., Boxrud D.J., Groom A.V., Steward C.D., Johnson S.K., Besser J.M., O'Boyle C., Danila R.N., Cheek J.E., Osterholm M.T., Moore K.A., and Smith K.E. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin. Infect. Dis. 33 (2001) 990-996
20. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., Johnson S.K., Vandenesch F., Fridkin S., O'Boyle C., Danila R.N., and Lynfield R. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
21. Oliveira D.C., and de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents. Chemother. 46 (2002) 2155-2161
22. Peacock S.J., Moore C.E., Justice A., Kantzanou M., Story L., Mackie K., O'Neill G., and Day N.P. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70 (2002) 4987-4996
23. Sakoulas G., Eliopoulos G.M., Moellering Jr. R.C., Novick R.P., Venkataraman L., Wennersten C., DeGirolami P.C., Schwaber M.J., and Gold H.S. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance?. J. Infect. Dis. 187 (2003) 929-938
24. Sakoulas G., Eliopoulos G.M., Moellering Jr. R.C., Wennersten C., Venkataraman L., Novick R.P., and Gold H.S. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents. Chemother. 46 (2002) 1492-1502
25. Siberry G.K., Tekle T., Carroll K., and Dick J. Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin. Infect. Dis. 37 (2003) 1257-1260
26. Tacconelli E., D'Agata E.M., and Karchmer A.W. Epidemiological comparison of true methicillin-resistant and methicillin-susceptible coagulase-negative staphylococcal bacteremia at hospital admission. Clin. Infect. Dis. 37 (2003) 644-649
27. Tenover F.C., Biddle J.W., and Lancaster M.V. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis. 7 (2001) 327-332
28. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulse-field gel electrophoresis criteria for bacterial strain typing. J. Clin. Microbiol. 33 (1995) 2233-2239
29. Zhang K., McClure J.A., Elsayed S., et al. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant staphylococcal aureus. J. Clin. Microbiol. 43 (2005) 5026-5033